Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Roquefort Investments PLC ( (GB:ROQ) ) is now available.
Roquefort Therapeutics PLC has announced a live interactive investor presentation scheduled for 29 September 2025. The presentation will discuss the proposed acquisition of Coiled Therapeutics, Inc. and its AO-252 clinical stage program from A2A Pharmaceuticals, Inc., potentially impacting the company’s strategic positioning in the biotech industry.
More about Roquefort Investments PLC
Roquefort Therapeutics PLC is a biotech company listed on the Main Market, focusing on innovative therapeutic solutions.
Average Trading Volume: 1,715,687
Technical Sentiment Signal: Sell
Current Market Cap: £2.83M
See more data about ROQ stock on TipRanks’ Stock Analysis page.